All Day Allergy Relief Capsule
NDC Package 63868-433-25
Package Information
All Day Allergy Relief (cetirizine hcl) capsules is cetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. This formulation utilizes a capsule delivery system. Marketed by Chain Drug Marketing Association Inc., this product is identified by NDC 63868-433 and is authorized under FDA application NDA022429.
Identification & Billing
- RxCUI: 1014675 - cetirizine HCl 10 MG 24HR Oral Capsule
- RxCUI: 1014675 - cetirizine hydrochloride 10 MG Oral Capsule
- RxCUI: 1014675 - cetirizine HCl 10 MG 24 HR Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63868 - Chain Drug Marketing Association Inc.
- 63868-433 - All Day Allergy Relief
- 63868-433-25 - 1 BOTTLE, PLASTIC in 1 BOX / 25 CAPSULE in 1 BOTTLE, PLASTIC
- 63868-433 - All Day Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63868-433-25 identifies a specific commercial package of 1 bottle, plastic in 1 box / 25 capsule in 1 bottle, plastic of All Day Allergy Relief, a human over the counter drug labeled by Chain Drug Marketing Association Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This capsule is formulated for oral use and contains cetirizine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Marketing Association Inc. on January 25, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Cetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Cetirizine does not prevent hives or prevent/treat a serious allergic reaction (such as anaphylaxis). Therefore, if your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use cetirizine in place of your epinephrine.
How is this Chain Drug Marketing Association Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868043325. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.